MED22 Antikörper (AA 2-140)
Kurzübersicht für MED22 Antikörper (AA 2-140) (ABIN7159124)
Target
Alle MED22 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 2-140
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Mediator of RNA polymerase II transcription subunit 22 protein (2-140AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- MED22 (Mediator Complex Subunit 22 (MED22))
-
Andere Bezeichnung
- MED22
-
Hintergrund
-
Background: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors.
Aliases: MED22 antibody, SURF5Mediator of RNA polymerase II transcription subunit 22 antibody, Mediator complex subunit 22 antibody, Surfeit locus protein 5 antibody, Surf-5 antibody
-
UniProt
- Q15528
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-